72
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Biomechanical Evaluation of Refractory Chronic Low Back Pain Treatment with Botulinum Toxin Type A

, MD, , MD, PhD, , MD, , MD & , MD
Pages 152-159 | Received 11 Nov 2012, Accepted 12 Jul 2013, Published online: 16 Apr 2014

References

  • Deyo RA, Mirza SK, Martin BI: Back pain prevalence and visit rates: Estimates from U.S. national survey. Spine 31: 2724–2727, 2002
  • Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P, Owens DK: Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 147: 478–491, 2007
  • Carpenter DM, Nelson BW: Low back strengthening for the prevention and treatment of low back pain. Med Sci Sports Exerc 31: 18–24, 1999
  • Wipf JE, Deyo RA: Low back pain. Med Clin North Am 79: 231–246, 1995
  • Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC: Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve 18: 720–729, 1995
  • Lang AM: Botulinum toxin type A therapy in chronic pain disorders. Arch Phys Med Rehabil 84: S69–S73, 2003
  • Lang AM: Botulinum toxin therapy for myofascial pain disorders. Curr Pain Headache Rep 6: 355–360, 2002
  • Foster L, Clapp L, Erickson M, Jabbari B: Botulinum toxin A and chronic low back pain: A randomized, double-blind study. Neurology 56: 1290–1293, 2001
  • Jabbari B, Ney J, Sichani A, Monacci W, Foster L, Difazio M: Treatment of refractory, chronic low back pain with botulinum neurotoxin A: An open-label, pilot study. Pain Med 7: 260–264, 2006
  • Ney JP, Difazio M, Sichani A, Monacci W, Foster L, Jabbari B: Treatment of chronic low back pain with successive injections of botulinum toxin a over 6 months: A prospective trial of 60 patients. Clin J Pain 22: 363–369, 2006
  • Danneels LA, Vanderstraeten GG, Cambier DC, Witvrouw EE, De Cuyper HJ: CT imaging of trunk muscles in chronic low back pain patients and healthy control subjects. Eur Spine J 9: 266–272, 2000
  • Fairbank JC, Couper J, Davies JB, O'Brien JP: The Oswestry low back pain disability questionnaire. Physiotherapy 66: 271–273, 1980
  • Difazio M, Jabbari B: A focused review of the use of botulinum toxins for low back pain. Clin J Pain 18: S155–S162, 2002
  • Jabbari B, Ney J: Treatment of low back pain with botulinum neurotoxins. Pain Pract 4: S47–S53, 2004
  • Nelson BW, O'Reilly E, Miller M, Hogan M, Wegner JA, Kelly C: The clinical effects of intensive, specific exercise on chronic low back pain: A controlled study of 895 consecutive patients with 1-year follow up. Orthopedics 18: 971–981, 1995
  • Lee JH, Hoshino Y, Nakamura K, Kariya Y, Saita K, Ito K: Trunk muscle weakness as a risk factor for low back pain. A 5-year prospective study. Spine 24: 54–57, 1999
  • Keller A, Brox JI, Gunderson R, Holm I, Friis A, Reikeras O: Trunk muscle strength, cross-sectional area, and density in patients with chronic low back pain randomized to lumbar fusion or cognitive intervention and exercises. Spine 29: 3–8, 2004
  • Lariviere C, Bilodeau M, Forqet R, Vadeboncoeur R, Mecheri H: Poor back muscle endurance is related to pain catastrophizing in patients with chronic low back pain. Spine 35: E1178–E1186, 2010

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.